期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

聚N-(2-羟丙基)甲基丙烯酰胺-肼屈嗪前药的合成及表征 被引量：1

Synthesis and characterization of PHPMA-HYD macromolecule prodrug
下载PDF
导出
摘要 研究聚N-(2-羟丙基)甲基丙烯酰胺-肼屈嗪(PHPMA-HYD)大分子前药的合成方法。以偶氮二异丁腈(AIBN)引发的聚合反应,制备药物载体PHPMA。然后以丁二酸酐为连接基团,将原药HYD连接在PHPMA上,得到了PHPMA-HYD大分子前药。对所得到的产物进行了紫外、FTIR、元素、DSC分析表征。检测结果显示前药中HYD的含量大于10.3%。该方法操作简单、易行,产率高。 The method for synthesis of PHPMA-HYD macromolecule prodrug was studied. With AIBN as radi- cal initiator, PHPMA was synthesized by polymerization reaction. Then HYD was connected onto PHPMA with succinic anhydride as the linker. PHPMA-HYD macromolecule prodrug was synthesized. The products were characterized by UV, FTIR, DSC and elementary analyisis. The content of HYD in the prodrug is more than 10. 3%. The method has the advantages of usable, easv and high yield.
作者 邢晓虎 张娟 张亚洲 钟林桔
机构地区 西北大学应用化学研究所
出处 《西北大学学报（自然科学版）》 CAS CSCD 北大核心 2014年第1期57-60,共4页 Journal of Northwest University（Natural Science Edition）
基金 陕西省教育厅科研计划基金资助项目(12JK0612)
关键词 前药 N-(2-羟丙基)甲基丙烯酰胺 肼屈嗪 酰化反应 prodrug PHPMA HYD acylation
分类号 O621.3 [理学—有机化学]
  • 相关文献

参考文献10

  • 1CAMPOS M,ESTIUEZ I,RAVIN E. Pyridazine derivatives XIV.study of the vasor-rel-axant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in Isolated rat thoracic aorta:co-mparison with hydralazine[J].{H}General Pharmacology,1998,(02):201-207.
  • 2EBEIGBE A,ALOAMAKA C. Mechanism of hydralazine induced relaxation of arterial smoo-tth muscle[J].Cardiovasc Research,1985.400-405.
  • 3VIDRIO H,FERNANDEZ G,MEDINA M. Eeffects of hydrazine derivatives on vascular smooth muscle contractility,blood pressure and cGMP production in rats:comparison with hydral-azine[J].{H}Vascular Pharmacology,2003.13-21.
  • 4MAGEE L A,CHAM C,WATERMAN E J. Hydralazine for treatment of severe hypertens-ion in pregnancy:metaanalysis[J].{H}British Medical Journal,2003.955-960.
  • 5KOPECEK J,KOPECKOVA P,MINKO T. HPMA copolymer-anticancer drug conjugat-e:design,activity,and mechanism of action[J].European Journal of Pharmacology and Biopharm-aceutics,2000.61-81.
  • 6ULHRICH K,SUBR V,STROHLALM J. Polymeric drugs based on eonjugates of synthet-ic and natural macromolecules I.Synthesis and physichemical characterization[J].Journal of Cont-rolled Release,2000.63-79.
  • 7STROHALM J,KOPECEK J. Poly[N-(2-hydroxypropyl) methacrylamide][J].Die Angewandte Makromolekulare Chemie,1978.109-118.
  • 8高丽娟,张娟,刘毅锋,乔长安,周永柱.聚[α,β-(N-2-乙羟基)-DL-天冬酰胺]-美他沙酮前药的合成与表征[J].西北大学学报（自然科学版）,2009,39(6):989-991. 被引量：3
  • 9周永柱,张娟,刘毅锋,谢俊.聚N-(2-羟丙基)甲基丙烯酰胺-美他沙酮前药的合成与表征[J].西北大学学报（自然科学版）,2010,40(5):825-827. 被引量：1
  • 10邢其毅;裴伟伟;徐瑞秋.基础有机化学[M]{H}北京:高等教育出版社,2005403-404.

二级参考文献12

  • 1汤谷平,单达先,陈启琪.高分子载体α，β－聚（羟烷基）－DL－天冬酰胺的合成及分子量测定[J].功能高分子学报,1994,7(4):445-449. 被引量：10
  • 2张娟,范晓东,刘毅锋,张亚洲,薄澜.大分子前药[J].化学通报,2005,68(9):659-666. 被引量：3
  • 3薄澜,张娟,刘毅锋,范晓东,张亚洲.N-氯乙酰基-5-芳氧甲基-2-噁唑烷酮类化合物的合成[J].西北大学学报（自然科学版）,2005,35(6):731-733. 被引量：5
  • 4ZHANG J, FAN X D,LIU Y F, et al. Synthesis of poly (ethyleneglycol)-metaxalone conjugates and study of its controlled release in vitro[ J]. Int J Pharm, 2007, 332: 125-131.
  • 5SCAIFE M, SHAH J. Method for increasing the bioavailability of metaxalone : US,6683102 [ P ]. 2004-01-27.
  • 6MOORE K A, LEVINE B, DAVID F. A fatality involving metaxalone [ J ]. Forensic Sci Int, 2005, 149 : 49- 251.
  • 7GIAMMONA G, GAVALLARO G, FONTANA G, et al. Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies[J]. J Controlled Release, 1998, 54 : 321-331.
  • 8GAVALLARO G, LICCIARDI M, CALICETI P, et al. Synthesis physico-chemical and biological characterization of a paelitaxel macromolecular prodrug[J].Eur J Pharm Biopharm, 2004, 58 (1) : 151-159.
  • 9GIAMMONA G, PUGLISI G, CAVALLARO G, et al. Chemical stability and bioavailabi lity of acyclovir coupled to α,β-poly ( N-2-hydroxyethyl ) -DL-aspartamide [ J ]. J Controlled Release, 1995, 33:261-271.
  • 10刘建国,李平,李萍,郑家燊.甲基丙烯酰氯制备方法的改进[J].化学试剂,2007,29(11):699-700. 被引量：9

共引文献2

同被引文献10

  • 1国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2005,附录:74.
  • 2IRENE A, PABLO D, RICARDO G,et al. Propafenone blocks human cardiac Kir2. x channels by decreasing the negative electrostatic charge in the cytoplasmic pore [ J ]. Biochemical Pharmacology,2013,86(2) :267-278.
  • 3TERRANCE P, DEBRA G. Propafenone Ingestion [ J ]. Annals of Emergency Medicine,1987,16(4) :437-440.
  • 4FIORENZO G, ELENA R, MARIO B, et al. Short-and long-term effects of propafenone in ventricutar arrhyth- mias [ ] ]. International Journal of Cardiology, 1986,13 (2) :163-170.
  • 5ADAM Y, DAVID S, HARJINDER P, et al. Acute propafenone toxicity after two exposures at standard dosing [ J ]. Canadian Journal of Cardiology, 2010,26 (6) : e209-e210.
  • 6LIU Xin-ming, SCOTT C, WANG Dong, et al. Be- yond oncology-application of HPMA copolymers in non-cancerous diseases [ J ]. Advanced Drug Delivery Reviews ,2010,62(2) :258-271.
  • 7ULHRICH K, SUBR V, STROHLALM J, et al. Poly- meric drugs based on eonjugates of synthetic and natu- ral macromolecules I. Synthesis and physichemical characterization [ J]. Journal of Controlled Release, 2000,64 : 63-79.
  • 8STROHALM J, KOPECEK J. Poly [ N- ( 2-hydroxyprop- yl) methacrylamide ] [ J ]. Die Angewandte Makromole- kulare Chemie, 1978,70 : 109-118.
  • 9牟博勇,蔺曜,曾朝富.普罗帕酮和胺碘酮及维拉帕米治疗阵发性室上性心动过速疗效的对比研究[J].实用心脑肺血管病杂志,2013,21(12):82-83. 被引量：16
  • 10景维本.“相似相溶原理”浅析[J].教学与管理（中学版）,1986,0(2):75-76. 被引量：3

引证文献1

西北大学学报（自然科学版）
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部